Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

33.3%

1 terminated/withdrawn out of 3 trials

Success Rate

0.0%

-86.5% vs industry average

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
1(33.3%)
Phase 4
1(33.3%)
Phase 2
1(33.3%)
3Total
N/A(1)
Phase 4(1)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT06481995Phase 4Recruiting

SWIFT - SWIss Factor XIII Trial in PPH

Role: lead

NCT07019623Not ApplicableRecruiting

U-CaVIT Versus Standard of Care for Prevention of Atonic Postpartum Hemorrhage After Cesarean Section in High-risk Women.

Role: lead

NCT05110599Phase 2Terminated

Bryophyllum Pinnatum Treatment of Anxiety Related to Signs of Preterm Birth

Role: lead

All 3 trials loaded